Side-effects of a monoclonal antibody, muromonab CD3/orthoclone OKT3: bibliographic review.
about
Immunotoxicity of monoclonal antibodiesRecent Progress towards Novel EV71 Anti-Therapeutics and VaccinesPlant-derived immunomodulators: an insight on their preclinical evaluation and clinical trialsMonoclonal antibody therapy and renal transplantation: focus on adverse effectsCase report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2Pharmacology and safety assessment of humanized monoclonal antibodies for therapeutic use.Structure guided homology model based design and engineering of mouse antibodies for humanization.The immunogenicity of humanized and fully human antibodies: residual immunogenicity resides in the CDR regionsHave we overestimated the benefit of human(ized) antibodies?Co-transplantation of human hematopoietic stem cells and human breast cancer cells in NSG mice: a novel approach to generate tumor cell specific human antibodies.Crystal structure of the human T cell receptor CD3 epsilon gamma heterodimer complexed to the therapeutic mAb OKT3.The birth pangs of monoclonal antibody therapeutics: the failure and legacy of CentoxinFunctional characterization of N297A, a murine surrogate for low-Fc binding anti-human CD3 antibodiesInfectious complications associated with monoclonal antibodies and related small moleculesResidual DNA analysis in biologics development: review of measurement and quantitation technologies and future directions.The history of monoclonal antibody development - Progress, remaining challenges and future innovationsBiologics that inhibit the Th17 pathway and related cytokines to treat inflammatory disorders.Therapeutic anti-CD3 monoclonal antibodies: from bench to bedside.Emerging trends and new developments in monoclonal antibodies: A scientometric analysis (1980-2016).A specific CD4 epitope bound by tregalizumab mediates activation of regulatory T cells by a unique signaling pathway.Antibody humanization by molecular dynamics simulations-in-silico guided selection of critical backmutations.De novo protein sequencing, humanization and in vitro effects of an antihuman CD34 mouse monoclonal antibody.Optimization of the crystallizability of a single-chain antibody fragment.Crystallization and preliminary X-ray structural studies of a high-affinity CD8alphaalpha co-receptor to pMHCHollow polydimethylsiloxane beads with a porous structure for cell encapsulation.Evaluation of immunotherapy to reverse sequestration in the treatment of severe Plasmodium falciparum malaria.Pharmacokinetics and antibody responses to the CD3 antibody otelixizumab used in the treatment of type 1 diabetes.Near-Infrared-Light-Assisted Photothermal Polymerization for Transdermal Hydrogelation and Cell Delivery.Potent and conditional redirected T cell killing of tumor cells using Half DVD-Ig.Exosomal Tat protein activates latent HIV-1 in primary, resting CD4+ T lymphocytes.
P2860
Q24653374-755499FF-5B5A-47A8-B430-B40EB7A44D08Q26775734-B053F003-BA49-49A0-A5CB-085ADDF83275Q26784434-F2A4E6A0-8A34-498F-B17C-7638C038D31AQ26826880-E6233503-C390-4048-B3E8-E861ACC5284CQ29620608-10627F68-655C-4E1B-83B3-7F4626647E86Q33657568-A0D3DAE6-39D3-4E8E-B5BF-6F4E6ED66BE6Q33803237-CCAC6B61-FB2D-43D4-957E-793E10F0CA35Q34110768-DAB252B6-8875-4B96-8AE1-2B560E419B85Q34142714-F0CC52CA-9199-466F-91C5-34A0BB35C878Q34223991-FA221034-094E-452F-9128-ED0D83D3D68CQ34336817-70FA79D8-F19E-4EE3-A238-20ADE3360C6BQ35969881-7A084CC5-A5A5-4091-840A-5A90FB51E7A4Q37106206-90BB0957-2164-49B4-93B6-69F186769713Q37156636-E6908863-D657-4256-BF0F-4FCDF47040D4Q37940194-A236E43F-D906-4E85-9E74-8127C60AF843Q38311132-438421B1-3547-4C61-8931-FD7A5C9ED4AAQ38632657-D2C5B734-A720-4B91-BBDA-83E1D34435D9Q38830417-3778E30E-0CD6-43B9-B5E8-462555F4508EQ38903356-07E0DBAB-7AE9-40CC-BEFC-047B98EFB254Q39887068-19074F4B-F34B-4611-91F2-365197469EC5Q40125548-1F33EF6E-58DD-4017-92FE-D40DCEE234CBQ41682470-0074A3C4-B928-4792-AC8F-29CFE4161314Q41718438-29B6E66A-8D59-474E-84E8-5FEC7846397AQ42411852-7A09D286-B37F-458B-9588-6534BD58A2AFQ42811772-AD4ED0D7-2BA8-4C7F-B5D3-0D4D4E167135Q44728497-04C25A90-745D-4CA2-A2B4-423C7381D8F4Q45050594-7DE2690A-577B-4409-AE0E-2D7D60E351E7Q46843576-84A0464D-E67B-4FA0-AF50-3BB5488434E2Q49260956-D5527261-1C24-4422-BCB1-25D870C25C9AQ52606459-144D4C23-93F0-4E5C-B2DA-AB31ACC85B3E
P2860
Side-effects of a monoclonal antibody, muromonab CD3/orthoclone OKT3: bibliographic review.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Side-effects of a monoclonal a ...... ne OKT3: bibliographic review.
@en
type
label
Side-effects of a monoclonal a ...... ne OKT3: bibliographic review.
@en
prefLabel
Side-effects of a monoclonal a ...... ne OKT3: bibliographic review.
@en
P1433
P1476
Side-effects of a monoclonal a ...... ne OKT3: bibliographic review.
@en
P2093
P356
10.1016/0300-483X(95)03123-W
P407
P577
1995-12-01T00:00:00Z